Published in Mamm Genome on May 21, 2007
Technical approaches for mouse models of human disease. Dis Model Mech (2011) 1.36
Interaction between environmental and genetic factors modulates schizophrenic endophenotypes in the Snap-25 mouse mutant blind-drunk. Hum Mol Genet (2009) 0.99
Optimising experimental design for high-throughput phenotyping in mice: a case study. Mamm Genome (2010) 0.98
Removing the cloak of invisibility: phenotyping the mouse. Dis Model Mech (2008) 0.90
New insights into behaviour using mouse ENU mutagenesis. Hum Mol Genet (2012) 0.80
A targeted deleterious allele of the splicing factor SCNM1 in the mouse. Genetics (2008) 0.79
High throughput sequencing approaches to mutation discovery in the mouse. Mamm Genome (2012) 0.76
The challenges for molecular nutrition research 3: comparative nutrigenomics research as a basis for entering the systems level. Genes Nutr (2008) 0.76
A new Otogelin ENU mouse model for autosomal-recessive nonsyndromic moderate hearing impairment. Springerplus (2015) 0.76
Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res (2005) 30.44
Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat (2003) 12.88
Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J Biol Chem (1999) 10.14
The knockout mouse project. Nat Genet (2004) 7.80
Talking about a revolution: The impact of site-specific recombinases on genetic analyses in mice. Dev Cell (2004) 7.06
A long-range Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly. Hum Mol Genet (2003) 6.82
An animal model for cystic fibrosis made by gene targeting. Science (1992) 5.75
Disruption of a long-range cis-acting regulator for Shh causes preaxial polydactyly. Proc Natl Acad Sci U S A (2002) 5.18
Know your neighbors: three phenotypes in null mutants of the myogenic bHLH gene MRF4. Cell (1996) 4.55
Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science (2003) 4.40
Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm Genome (1997) 4.15
Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nat Genet (2000) 3.92
PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects. Cell (2004) 3.87
A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse. Nat Genet (2000) 3.63
The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling. Hum Mol Genet (2006) 3.39
F0 generation mice fully derived from gene-targeted embryonic stem cells allowing immediate phenotypic analyses. Nat Biotechnol (2006) 3.13
Mutations in alpha-tubulin cause abnormal neuronal migration in mice and lissencephaly in humans. Cell (2007) 3.06
Function of quaking in myelination: regulation of alternative splicing. Proc Natl Acad Sci U S A (2002) 3.04
Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature (1992) 2.86
Apoptosis: final common pathway of photoreceptor death in rd, rds, and rhodopsin mutant mice. Neuron (1993) 2.83
The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function coordinately during embryonic angiogenesis. J Biol Chem (2004) 2.62
Mutation spectrum of the gene encoding the beta subunit of rod phosphodiesterase among patients with autosomal recessive retinitis pigmentosa. Proc Natl Acad Sci U S A (1995) 2.41
Mendelian disorders deserve more attention. Nat Rev Genet (2006) 2.36
Genotype-based screen for ENU-induced mutations in mouse embryonic stem cells. Nat Genet (2000) 2.24
Random mutagenesis in the mouse as a tool in drug discovery. Drug Discov Today (2002) 2.23
Dose-repetition increases the mutagenic effectiveness of N-ethyl-N-nitrosourea in mouse spermatogonia. Proc Natl Acad Sci U S A (1985) 2.22
Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A. Nat Genet (1992) 2.04
Knockouts model the 100 best-selling drugs--will they model the next 100? Nat Rev Drug Discov (2003) 1.99
A protocol for high-throughput phenotyping, suitable for quantitative trait analysis in mice. Mamm Genome (2006) 1.96
A gene-driven ENU-based approach to generating an allelic series in any gene. Mamm Genome (2004) 1.82
Functions of mammalian Smad genes as revealed by targeted gene disruption in mice. Cytokine Growth Factor Rev (2000) 1.81
Marker-assisted introgression in backcross breeding programs. Genetics (1996) 1.81
Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy. Hum Mutat (2003) 1.79
Mice without myoglobin. Nature (1998) 1.78
Neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med (2001) 1.78
A gene-driven approach to the identification of ENU mutants in the mouse. Nat Genet (2002) 1.76
Knockout mouse fault lines. Nature (1995) 1.73
Multiple mutations in mouse Chd7 provide models for CHARGE syndrome. Hum Mol Genet (2005) 1.71
Differential expression of dystrophin isoforms in strains of mdx mice with different mutations. Hum Mol Genet (1996) 1.69
Role of Smad4 (DPC4) inactivation in human cancer. Biochem Biophys Res Commun (2003) 1.65
Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nat Genet (1995) 1.60
Genetic analysis of glucose tolerance in inbred mouse strains. Evidence for polygenic control. Diabetes (1988) 1.56
N-ethyl-N-nitrosourea mutagenesis: boarding the mouse mutant express. Microbiol Mol Biol Rev (2005) 1.54
A comparison of 129S2/SvHsd and C57BL/6JOlaHsd mice on a test battery assessing sensorimotor, affective and cognitive behaviours: implications for the study of genetically modified mice. Behav Brain Res (2001) 1.51
Phylogenetic conservation of a limb-specific, cis-acting regulator of Sonic hedgehog ( Shh). Mamm Genome (2004) 1.46
Novel ENU-induced eye mutations in the mouse: models for human eye disease. Hum Mol Genet (2002) 1.41
Glucokinase mutations associated with non-insulin-dependent (type 2) diabetes mellitus have decreased enzymatic activity: implications for structure/function relationships. Proc Natl Acad Sci U S A (1993) 1.40
Molecular genetic dissection of mouse unconventional myosin-VA: tail region mutations. Genetics (1998) 1.38
A leucine-to-proline mutation in the putative first transmembrane domain of the 22-kDa peripheral myelin protein in the trembler-J mouse. Proc Natl Acad Sci U S A (1992) 1.36
Systematic approaches to mouse mutagenesis. Curr Opin Genet Dev (2001) 1.35
Mutants of glucokinase cause hypoglycaemia- and hyperglycaemia syndromes and their analysis illuminates fundamental quantitative concepts of glucose homeostasis. Diabetologia (1999) 1.33
Genotype-phenotype correlation of mouse pde6b mutations. Invest Ophthalmol Vis Sci (2005) 1.31
Capitalizing on large-scale mouse mutagenesis screens. Nat Rev Genet (2000) 1.30
Diminished growth and enhanced glucose metabolism in triple knockout mice containing mutations of insulin-like growth factor binding protein-3, -4, and -5. Mol Endocrinol (2006) 1.29
A mutation in Af4 is predicted to cause cerebellar ataxia and cataracts in the robotic mouse. J Neurosci (2003) 1.29
A series of maturity onset diabetes of the young, type 2 (MODY2) mouse models generated by a large-scale ENU mutagenesis program. Hum Mol Genet (2004) 1.24
Large scale ENU screens in the mouse: genetics meets genomics. Mutat Res (1998) 1.24
Estimating the number of coding mutations in genotypic- and phenotypic-driven N-ethyl-N-nitrosourea (ENU) screens. Mamm Genome (2006) 1.24
Mutation rate and predicted phenotypic target sizes in ethylnitrosourea-treated mice. Genetics (2004) 1.23
Consequences of mutations in the non-coding RMRP RNA in cartilage-hair hypoplasia. Hum Mol Genet (2005) 1.19
Mutation analysis of the mouse myosin VIIA deafness gene. Genes Funct (1997) 1.19
A series of ENU-induced single-base substitutions in a long-range cis-element altering Sonic hedgehog expression in the developing mouse limb bud. Genomics (2006) 1.16
Molecular characterization of ENU mouse mutagenesis and archives. Biochem Biophys Res Commun (2005) 1.15
An Oak Ridge legacy: the specific locus test and its role in mouse mutagenesis. Genetics (1998) 1.14
Molecular characterization of Pax6(2Neu) through Pax6(10Neu): an extension of the Pax6 allelic series and the identification of two possible hypomorph alleles in the mouse Mus musculus. Genetics (2001) 1.13
Deletion of the Parkin coregulated gene causes male sterility in the quaking(viable) mouse mutant. Proc Natl Acad Sci U S A (2004) 1.13
Three ENU-induced alleles of the murine quaking locus are recessive embryonic lethal mutations. Genet Res (1988) 1.12
Efficient and fast targeted production of murine models based on ENU mutagenesis. Mamm Genome (2005) 1.11
Genetic and allelic heterogeneity of Cryg mutations in eight distinct forms of dominant cataract in the mouse. Invest Ophthalmol Vis Sci (2004) 1.10
PMP22 carrying the trembler or trembler-J mutation is intracellularly retained in myelinating Schwann cells. Neurobiol Dis (2000) 1.10
The broken mouse: the role of development, plasticity and environment in the interpretation of phenotypic changes in knockout mice. Curr Opin Neurobiol (2000) 1.10
The human homolog of the QKI gene affected in the severe dysmyelination "quaking" mouse phenotype: downregulated in multiple brain regions in schizophrenia. Am J Psychiatry (2006) 1.09
Altered lymphoid development in mice deficient for the mAF4 proto-oncogene. Blood (2000) 1.09
Mouse models created to study the pathophysiology of Type 2 diabetes. Int J Biochem Cell Biol (2005) 1.08
Molecular genetic dissection of mouse unconventional myosin-VA: head region mutations. Genetics (1998) 1.06
An allelic series of mutations in Smad2 and Smad4 identified in a genotype-based screen of N-ethyl-N- nitrosourea-mutagenized mouse embryonic stem cells. Proc Natl Acad Sci U S A (2002) 1.05
Gene therapy for cystic fibrosis lung disease: current status and future perspectives. Curr Opin Mol Ther (2006) 1.04
Adaptive mechanisms that preserve cardiac function in mice without myoglobin. Circ Res (2001) 1.04
Mouse models in tumor suppression. Oncogene (1998) 1.04
ENU mutagenesis reveals a highly mutable locus on mouse Chromosome 4 that affects ear morphogenesis. Mamm Genome (2002) 1.03
Combining mutagenesis and genomics in the mouse--closing the phenotype gap. Trends Genet (1996) 1.03
Comparison of fluorescent single-strand conformation polymorphism analysis and denaturing high-performance liquid chromatography for detection of EXT1 and EXT2 mutations in hereditary multiple exostoses. Eur J Hum Genet (2000) 1.02
A comparison of the dominant cataract and recessive specific-locus mutation rates induced by treatment of male mice with ethylnitrosourea. Mutat Res (1983) 1.02
The dominant alopecia phenotypes Bareskin, Rex-denuded, and Reduced Coat 2 are caused by mutations in gasdermin 3. Genomics (2004) 0.99
Spectrum of Bmp5 mutations from germline mutagenesis experiments in mice. Genetics (1997) 0.99
Contrasting effects of ENU induced embryonic lethal mutations of the quaking gene. Genomics (1999) 0.99
The mousetrap: what we can learn when the mouse model does not mimic the human disease. ILAR J (2002) 0.98
Saturation mutagenesis for dominant eye morphological defects in the mouse Mus musculus. Mamm Genome (2000) 0.98
Tagging genes with cassette-exchange sites. Nucleic Acids Res (2005) 0.98
A new mouse model of type 2 diabetes, produced by N-ethyl-nitrosourea mutagenesis, is the result of a missense mutation in the glucokinase gene. Diabetes (2004) 0.97
Single base pair change in the long-range Sonic hedgehog limb-specific enhancer is a genetic basis for preaxial polydactyly. Dev Dyn (2005) 0.97
The robotic mouse: unravelling the function of AF4 in the cerebellum. Cerebellum (2005) 0.95
Three ENU-induced neurological mutations in the pore loop of sodium channel Scn8a (Na(v)1.6) and a genetically linked retinal mutation, rd13. Mamm Genome (2004) 0.94
Identification of two new Pmp22 mouse mutants using large-scale mutagenesis and a novel rapid mapping strategy. Hum Mol Genet (2000) 0.93
Efficient gene-driven germ-line point mutagenesis of C57BL/6J mice. BMC Genomics (2005) 0.92
Gene trap mutagenesis in embryonic stem cells. Methods Enzymol (2003) 0.92
A new ENU-induced allele of mouse quaking causes severe CNS dysmyelination. Mamm Genome (2005) 0.91
Additive effect of p53, p21 and Rb deletion in triple knockout primary hepatocytes. Oncogene (2004) 0.90
Mediation of Af4 protein function in the cerebellum by Siah proteins. Proc Natl Acad Sci U S A (2004) 0.90
A functional genetic link between distinct developmental language disorders. N Engl J Med (2008) 4.99
Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev (2002) 4.80
The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling. Hum Mol Genet (2006) 3.39
Mutations in alpha-tubulin cause abnormal neuronal migration in mice and lissencephaly in humans. Cell (2007) 3.06
Pharmacological strategies for muscular dystrophy. Nat Rev Drug Discov (2003) 2.32
Long noncoding RNA genes: conservation of sequence and brain expression among diverse amniotes. Genome Biol (2010) 2.20
Current status of pharmaceutical and genetic therapeutic approaches to treat DMD. Mol Ther (2011) 2.06
Hsp72 preserves muscle function and slows progression of severe muscular dystrophy. Nature (2012) 2.04
High-throughput analysis of promoter occupancy reveals direct neural targets of FOXP2, a gene mutated in speech and language disorders. Am J Hum Genet (2007) 2.01
Functional genetic analysis of mutations implicated in a human speech and language disorder. Hum Mol Genet (2006) 1.85
Neuromuscular defects in a Drosophila survival motor neuron gene mutant. Hum Mol Genet (2003) 1.85
Alternative splicing events are a late feature of pathology in a mouse model of spinal muscular atrophy. PLoS Genet (2009) 1.76
Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches. Nat Rev Genet (2013) 1.70
Novel markers reveal subpopulations of subplate neurons in the murine cerebral cortex. Cereb Cortex (2008) 1.67
Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment. EMBO Rep (2004) 1.66
A point mutation in TRPC3 causes abnormal Purkinje cell development and cerebellar ataxia in moonwalker mice. Proc Natl Acad Sci U S A (2009) 1.66
Foxp2 regulates gene networks implicated in neurite outgrowth in the developing brain. PLoS Genet (2011) 1.56
Utrophin binds laterally along actin filaments and can couple costameric actin with sarcolemma when overexpressed in dystrophin-deficient muscle. Mol Biol Cell (2002) 1.44
Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with beta-dystroglycan. J Cell Biol (2007) 1.39
Expansion of revertant fibers in dystrophic mdx muscles reflects activity of muscle precursor cells and serves as an index of muscle regeneration. J Cell Sci (2006) 1.34
Prevention of dystrophic pathology in severely affected dystrophin/utrophin-deficient mice by morpholino-oligomer-mediated exon-skipping. Mol Ther (2009) 1.31
Therapeutic approaches to muscular dystrophy. Hum Mol Genet (2011) 1.30
A mutation in Af4 is predicted to cause cerebellar ataxia and cataracts in the robotic mouse. J Neurosci (2003) 1.29
Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse. PLoS One (2011) 1.29
Identification and characterization of murine SCARA5, a novel class A scavenger receptor that is expressed by populations of epithelial cells. J Biol Chem (2006) 1.25
A dominant mutation in Snap25 causes impaired vesicle trafficking, sensorimotor gating, and ataxia in the blind-drunk mouse. Proc Natl Acad Sci U S A (2007) 1.22
A mutation in the small heat-shock protein HSPB1 leading to distal hereditary motor neuronopathy disrupts neurofilament assembly and the axonal transport of specific cellular cargoes. Hum Mol Genet (2005) 1.21
Diaphragm rescue alone prevents heart dysfunction in dystrophic mice. Hum Mol Genet (2010) 1.19
LEKTI is localized in lamellar granules, separated from KLK5 and KLK7, and is secreted in the extracellular spaces of the superficial stratum granulosum. J Invest Dermatol (2005) 1.19
Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases. Mol Ther (2013) 1.16
Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin. J Cell Sci (2010) 1.14
Oxr1 is essential for protection against oxidative stress-induced neurodegeneration. PLoS Genet (2011) 1.13
ZZ domain is essentially required for the physiological binding of dystrophin and utrophin to beta-dystroglycan. Hum Mol Genet (2004) 1.12
Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping. Hum Mol Genet (2012) 1.10
Identification of valid housekeeping genes for quantitative RT-PCR analysis of cardiosphere-derived cells preconditioned under hypoxia or with prolyl-4-hydroxylase inhibitors. Mol Biol Rep (2011) 1.10
The Pathogenesis and Therapy of Muscular Dystrophies. Annu Rev Genomics Hum Genet (2015) 1.08
Deletion of smn-1, the Caenorhabditis elegans ortholog of the spinal muscular atrophy gene, results in locomotor dysfunction and reduced lifespan. Hum Mol Genet (2008) 1.08
Evidence for a dominant-negative effect in ACTA1 nemaline myopathy caused by abnormal folding, aggregation and altered polymerization of mutant actin isoforms. Hum Mol Genet (2004) 1.08
Mouse models of dominant ACTA1 disease recapitulate human disease and provide insight into therapies. Brain (2011) 1.08
Dystrophin- and MLP-deficient mouse hearts: marked differences in morphology and function, but similar accumulation of cytoskeletal proteins. FASEB J (2004) 1.07
Muscular dystrophy--reason for optimism? Cell (2002) 1.07
A- and B-utrophin have different expression patterns and are differentially up-regulated in mdx muscle. J Biol Chem (2002) 1.07
Generation and characterization of transgenic mice with the full-length human DMD gene. J Biol Chem (2007) 1.07
The effect of pre-mutation of X chromosome CGG trinucleotide repeats on brain anatomy. Brain (2004) 1.06
Evaluating the links between schizophrenia and sleep and circadian rhythm disruption. J Neural Transm (Vienna) (2012) 1.05
A-utrophin up-regulation in mdx skeletal muscle is independent of regeneration. Neuromuscul Disord (2004) 1.05
AAV genome loss from dystrophic mouse muscles during AAV-U7 snRNA-mediated exon-skipping therapy. Mol Ther (2013) 1.03
Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model. Neurobiol Dis (2009) 1.02
SNARE proteins and schizophrenia: linking synaptic and neurodevelopmental hypotheses. Acta Biochim Pol (2008) 1.02
The protein phosphatase PP2A-B' subunit Widerborst is a negative regulator of cytoplasmic activated Akt and lipid metabolism in Drosophila. J Cell Sci (2008) 1.01
Enhanced exon-skipping induced by U7 snRNA carrying a splicing silencer sequence: Promising tool for DMD therapy. Mol Ther (2009) 1.00
Abnormal cardiac morphology, function and energy metabolism in the dystrophic mdx mouse: an MRI and MRS study. J Mol Cell Cardiol (2008) 1.00
Association of syncoilin and desmin: linking intermediate filament proteins to the dystrophin-associated protein complex. J Biol Chem (2001) 1.00
The role of utrophin in the potential therapy of Duchenne muscular dystrophy. Neuromuscul Disord (2002) 0.99
Rescue of skeletal muscle alpha-actin-null mice by cardiac (fetal) alpha-actin. J Cell Biol (2009) 0.99
Interaction between environmental and genetic factors modulates schizophrenic endophenotypes in the Snap-25 mouse mutant blind-drunk. Hum Mol Genet (2009) 0.99
Utrophin up-regulation by an artificial transcription factor in transgenic mice. PLoS One (2007) 0.98
A motor function for the DEAD-box RNA helicase, Gemin3, in Drosophila. PLoS Genet (2008) 0.98
In vivo MRI characterization of progressive cardiac dysfunction in the mdx mouse model of muscular dystrophy. PLoS One (2012) 0.98
Progress in therapy for Duchenne muscular dystrophy. Exp Physiol (2011) 0.96
Discovery of 2-arylbenzoxazoles as upregulators of utrophin production for the treatment of Duchenne muscular dystrophy. J Med Chem (2011) 0.96
Disrupted circadian rhythms in a mouse model of schizophrenia. Curr Biol (2012) 0.96
Safety, tolerability, and pharmacokinetics of SMT C1100, a 2-arylbenzoxazole utrophin modulator, following single- and multiple-dose administration to healthy male adult volunteers. J Clin Pharmacol (2015) 0.95
Chondrolectin affects cell survival and neuronal outgrowth in in vitro and in vivo models of spinal muscular atrophy. Hum Mol Genet (2013) 0.93
The allure of stem cell therapy for muscular dystrophy. Neuromuscul Disord (2007) 0.92
Compensation for dystrophin-deficiency: ADAM12 overexpression in skeletal muscle results in increased alpha 7 integrin, utrophin and associated glycoproteins. Hum Mol Genet (2003) 0.91
Mediation of Af4 protein function in the cerebellum by Siah proteins. Proc Natl Acad Sci U S A (2004) 0.90
Analysis of human neurological disorders using mutagenesis in the mouse. Clin Sci (Lond) (2005) 0.89
Dismutase-competent SOD1 mutant accumulation in myelinating Schwann cells is not detrimental to normal or transgenic ALS model mice. Hum Mol Genet (2009) 0.88
Engineering multiple U7snRNA constructs to induce single and multiexon-skipping for Duchenne muscular dystrophy. Mol Ther (2012) 0.88
A combined metabolomic and proteomic investigation of the effects of a failure to express dystrophin in the mouse heart. J Proteome Res (2008) 0.88
Behavioural characterisation of the robotic mouse mutant. Behav Brain Res (2007) 0.87
Intermediate filament-like protein syncoilin in normal and myopathic striated muscle. Neuromuscul Disord (2007) 0.86
The robotic mouse: understanding the role of AF4, a cofactor of transcriptional elongation and chromatin remodelling, in purkinje cell function. Cerebellum (2009) 0.86
Isolation and culture of motor neurons from the newborn mouse spinal cord. Brain Res Brain Res Protoc (2004) 0.86
Pharmacologically targeting the primary defect and downstream pathology in Duchenne muscular dystrophy. Curr Gene Ther (2012) 0.86
Syncoilin upregulation in muscle of patients with neuromuscular disease. Muscle Nerve (2005) 0.85
Candidate screening of the TRPC3 gene in cerebellar ataxia. Cerebellum (2011) 0.85
AF4 is a critical regulator of the IGF-1 signaling pathway during Purkinje cell development. J Neurosci (2009) 0.85
Microarray analysis of mdx mice expressing high levels of utrophin: therapeutic implications for dystrophin deficiency. Neuromuscul Disord (2008) 0.84
Actin nemaline myopathy mouse reproduces disease, suggests other actin disease phenotypes and provides cautionary note on muscle transgene expression. PLoS One (2011) 0.84
Is good housekeeping the key to motor neuron survival? Cell (2008) 0.83
Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy. Skelet Muscle (2011) 0.82
Gene expression profiling studies on Caenorhabditis elegans dystrophin mutants dys-1(cx-35) and dys-1(cx18). Genomics (2006) 0.82
Muscular dystrophies related to the cytoskeleton/nuclear envelope. Novartis Found Symp (2005) 0.81
Syncoilin isoform organization and differential expression in murine striated muscle. J Struct Biol (2008) 0.81
New insights into behaviour using mouse ENU mutagenesis. Hum Mol Genet (2012) 0.80
The role of intermediate filament proteins in the development of neurological disease. Crit Rev Neurobiol (2007) 0.80
Analysis of skeletal muscle function in the C57BL6/SV129 syncoilin knockout mouse. Mamm Genome (2008) 0.80
Identification of a new Pmp22 mouse mutant and trafficking analysis of a Pmp22 allelic series suggesting that protein aggregates may be protective in Pmp22-associated peripheral neuropathy. Mol Cell Neurosci (2002) 0.80
Syncoilin modulates peripherin filament networks and is necessary for large-calibre motor neurons. J Cell Sci (2010) 0.80
Expression profiling in spinal muscular atrophy reveals an RNA binding protein deficit. Neuromuscul Disord (2004) 0.79
Activation of mutant protein kinase Cgamma leads to aberrant sequestration and impairment of its cellular function. Biochem Biophys Res Commun (2008) 0.78
Syncoilin accumulation in two patients with desmin-related myopathy. Neuromuscul Disord (2003) 0.78
Preconditioning of Cardiosphere-Derived Cells With Hypoxia or Prolyl-4-Hydroxylase Inhibitors Increases Stemness and Decreases Reliance on Oxidative Metabolism. Cell Transplant (2015) 0.78
Spinal muscular atrophy at the crossroads of basic science and therapy. Neuromuscul Disord (2012) 0.78
Ets, Ap-1 and GATA factor families regulate the utrophin B promoter: potential regulatory mechanisms for endothelial-specific expression. FEBS Lett (2003) 0.77
A new way to regulate the NMJ. Nat Med (2007) 0.76